Transvaginal mesh is a type of surgical mesh used for the repair of common pelvic floor disorders including pelvic organ prolapse. It is sometimes called a bladder sling. It is designed to shore up organs, such as the bladder and uterus that have dropped, or prolapsed, due to age, obesity or childbirth. These pelvic floor disorders are relatively common conditions and can cause symptoms such as urinary incontinence, and pain or discomfort.
The FDA has issued a safety communication warning doctors, health care professionals and patients that the placement of surgical mesh through the vagina to treat pelvic organ prolapse may present greater risk for the patient than other options.
The agency reported that between 2008-2010, more than 1,500 reports of problems associated with the devices in the repair of pelvic organ prolapse had been recorded — five times more than what the agency received between 2005-2007.
According to the FDA, reported complications from the transvaginal placement of the mesh include erosion of the mesh into the vaginal tissue, organ perforation, pain, infection, painful intercourse, and urinary and fecal incontinence. Often women require surgery to remove the mesh. In some cases, this can require multiple procedures without successfully removing all the mesh.
Women who have received transvaginal mesh or bladder slings to repair pelvic floor disorders such as pelvic organ prolapse (POP) or urinary incontinence and are experiencing problems may not realize that they may be able to hold the manufacturer of the devices liable and receive compensation for their pain and suffering.
Currently, we are investigating cases involving mesh manufactured by American Medical Systems, Bard, Boston Scientific, Caldera and Johnson & Johnson.